LaFleur & Godfrey’s iShares US Medical Devices ETF IHI Stock Holding History

LaFleur & Godfrey’s Portfolio IHI Stock Details IHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$302K	Buy	6,112 +923	+18%	+$46.9K	0.04%	130
2026 Q1	$277K	Buy	5,189 +169	+3%	+$9.92K	0.03%	128
2025 Q4	$312K	Buy	5,020 +638	+15%	+$39.4K	0.04%	127
2025 Q3	$263K	Buy	4,382 +331	+8%	+$20.2K	0.03%	128
2025 Q2	$254K	Buy	4,051 +10	+0.2%	+$601	0.03%	129
2025 Q1	$243K	Buy	4,041 +236	+6%	+$14.7K	0.03%	131
2024 Q4	$222K	Buy	3,805 +228	+6%	+$13.6K	0.03%	138
2024 Q3	$212K	Buy	+3,577	New	+$204K	0.03%	138

Other funds holding IHI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

AAS

Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

LaFleur & Godfrey's IHI Position: Q2 2026 in Review

LaFleur & Godfrey increased its iShares US Medical Devices ETF (IHI) stake by 18% in Q2 2026, buying an estimated $46.9K and bringing the position to 6,112 shares worth $302K. The position accounts for 0.04% of the portfolio, ranked #130.

LaFleur & Godfrey first reported a position in IHI in Q3 2024 and has held it in 8 quarters since. The position peaked at $312K in Q4 2025. 501 funds tracked by Wall St. Rank hold IHI as of Q2 2026.

LaFleur & Godfrey held 6,112 shares of iShares US Medical Devices ETF worth $302K as of Q2 2026.
LaFleur & Godfrey bought 923 iShares US Medical Devices ETF shares in Q2 2026, an estimated $46.9K.
iShares US Medical Devices ETF made up 0.04% of LaFleur & Godfrey's portfolio in Q2 2026, its #130 holding.
LaFleur & Godfrey first reported a position in iShares US Medical Devices ETF in Q3 2024 and has held it in 8 quarters since.
LaFleur & Godfrey's iShares US Medical Devices ETF position peaked at $312K in Q4 2025.
501 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.

Based on LaFleur & Godfrey's 13F filing for Q2 2026, filed 15 Jul 2026.